• BX Home
  • Drug Prices: News [Page 2]

Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

DRUG PRICES

As the prices of prescription drugs skyrocket in oncology and other disease areas, there is a danger payers will scale back coverage of these life-saving products. How can society cope with these escalating drug costs? Where is this crisis headed, and what measures are drug companies, regulators and lawmakers willing or able to implement?

Drug Prices is part of Business Exchange, suggested by Neil Gross. This topic contains 423 news and 97 blog items. Read updated news, blogs, and resources about Drug Prices. Find user-submitted articles and reactions on Drug Prices from like-minded professionals.

News

Please add new articles to this topic

U.K. Rejects Three Costly Leukemia Drugsmore

In another sign of growing opposition to high drug prices, an arm of the U.K.'s health-care system said Britain...

US FTC: drug patent kickback deals up by 60 pctmore

keep generics off the market are already costing consumers and taxpayers $3.5 billion a year in higher drug...

Fresenius Medical Care Reports Strong Start For 2011 And Raises Guidan...more

increased from 15.7% to 15.8%. The margin development was mainly influenced by the favorable development of...

FTC���s Leibowitz Says Rising Generic Drug Deals Hurt Consumersmore

on the issue. ���The FTC���s efforts here can make a real contribution to helping to control escalating drug prices,���...

Drugmaker Patent Accords Delaying Generics Up 63%, FTC Saysmore

keep generics off the market are already costing consumers and taxpayers $3.5 billion a year in higher drug prices,���...

US FTC: drug patent kickback deals up by 60 pctmore

keep generics off the market are already costing consumers and taxpayers $3.5 billion a year in higher drug...

McKesson profit up 21%, expects stable drug pricesmore

SAN FRANCISCO (MarketWatch) -- McKesson Corp. (NYSE:MCK)

FTC���s Leibowitz Denounces Patent Accords That Delay Genericsmore

keep generics of the market are already costing consumers and taxpayers $3.5 billion a year in higher drug prices,���...

Biocon Profit Jumps 25%more

forced to cut prices of its products by the German government, which has been trying to drive down drug prices and make...

Reportlinker Adds The Outlook For Pharmaceuticals In Latin Americamore

At a regional level, MERCOSUR members have decided to establish a drug price database to compare and monitor drug...

Dramatic Price Increases In Brand Name Drugs Spur Shareholders To Acti...more

Johnson and Johnson, Abbott, Bristol-Myers Squibb and Pfizer, requesting that management utilize a combination of...

Court questions limits on use of prescription datamore

a reported $8 billion a year marketing their products to doctors.Backers of the laws generally believe that drug prices...

Pinning hopes on pharmamore

a pharmaceutical industry analyst with the CIC Industry Research Center. He added that government policies designed to...

The House Progressive Budgetmore

d be a public option added to the health-care system and Medicare would get more power to negotiate drug prices.

Beyond the cliff, dividends, M&A beckon for big pharmamore

past two years. The lack of new breakthrough discoveries combined with growing pressures from indebted governments to...

China's health reform cuts drug prices, but still fights pain (2)more

shows several repriced medicines at a pharmacy in Shenyang, capital of northeast China's Liaoning Province, March 28,...

China's health reform cuts drug prices, but still fights painmore

facing China's health system and easing public grievances. Two years later, the essential medicine system has reduced...

China's health reform cuts drug prices, but still fights painmore

facing China's health system and easing public grievances. Two years later, the essential medicine system has reduced...

Two very different approaches to a budget dealmore

to deficit reduction. There���s no strong public option, and Medicare doesn���t get the power to negotiate drug prices.

UPDATE 3-Canada's Metro eyes benefits from inflation after dull Q2more

drove Empire to report a lower quarterly profit. [ID:nN08154770] New drug laws in Quebec and Ontario lowered drug...

Metro eyes benefits from inflation after dull Q2more

food prices drove Empire to report a lower quarterly profit. New drug laws in Quebec and Ontario lowered drug prices,...

Of course many in Congress don���t want to control Medicare costsmore

Liberals see it similarly, though with a more corporate spin: Medicare Part D doesn���t negotiate for low drug prices...

UPDATE 2-Grocer Metro's Q2 profit misses view as competition hits homemore

commodities such as wheat, rice and fresh produce to consumers. New drug laws in Quebec and Ontario lowered drug...

Carl Lewis's run for political office gets off to a rocky startmore

and raise their kids here, that our seniors can remain in their homes and afford their health and pharmaceutical...

2011 Budget Battle Only the First of Many to Comemore

ways to cut down on waste in Medicare, and by using Medicare's purchasing power to negotiate better drug prices.

Top Sources: Drug Prices

  • New York Times
  • MarketWatch
  • Forbes.com
  • Economictimes
  • online.wsj.com
  • Chicago Tribune
  • in.sys-con.com
  • bloomberg.com
  • Globe and Mail
  • startribune.com

Most Active Users in this Topic

see all contributors in Drug Prices

Featured White Papers

Post a Job

Jobs in this Topic

Analyst - Strategic Pricing Job Novo Nordisk | Princeton, NJ
Posted: Jun 4
Vice President Strategic Pricing (Pharmaceutical Background) H. D. Smith Wholesale Drug Co. | Springfield, IL
Posted: Jun 19
Cost Accountant H. D. Smith Wholesale Drug Co. | Springfield, IL
Posted: Jun 10
Finance Manager - Pricing Novo Nordisk | Princeton, NJ
Posted: Jul 9
Director, Market Access, Pricing and Reimbursement XOMA | Berkeley, CA
Posted: Jun 12

Report comment contains invalid characters. ()
cancel
Search Cancel